Avid Bioservices Inc (CDMO)

[EYEBUYSTOX]

I don't think you understand my point. Even if bavituximab ultimately helps the PD-1 drugs, the FDA will require phase 1, 2 and 3 data. It's 5-10 years away minimum.

Here's a fact:

If Opdivo beats docetaxel alone by a lot, a 100% mos improvement successful PPHM SUNRISE trial will be at risk for not receiving approval due to the use of a no longer valid control arm JUST LIKE COTARA WAS BACK IN THE DAY!